Operator of a preclinical-stage biotechnology company intended to improve the treatment of patients with cancer. The company's proprietary oncolytic virus platform is designed to address key limitatio...

Healthcare
New York, NY, United States
Founded 2018
12 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$97.2M
Last Round
N/A